Adenosine A2a Receptor 抗体 (AA 291-412)
-
- 抗原 See all Adenosine A2a Receptor (ADORA2A) 抗体
- Adenosine A2a Receptor (ADORA2A)
-
抗原表位
- AA 291-412
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Adenosine A2a Receptor antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Adenosine receptor A2a protein (291-412AA)
- 亚型
- IgG
- Top Product
- Discover our top product ADORA2A Primary Antibody
-
-
- 应用备注
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- Adenosine A2a Receptor (ADORA2A)
- 别名
- ADORA2A (ADORA2A 产品)
- 别名
- ADORA2A antibody, adora2a.1 antibody, zgc:194773 antibody, A2aR antibody, ADORA2 antibody, RDC8 antibody, A2AAR antibody, AA2AR antibody, A2ar antibody, ADENO antibody, Adora2l1 antibody, adora2a.2 antibody, zgc:193802 antibody, zgc:193822 antibody, adenosine A2a receptor antibody, adenosine A2a receptor a antibody, adenosine A2a receptor L homeolog antibody, adenosine A2a receptor b antibody, ADORA2A antibody, Adora2a antibody, adora2aa antibody, adora2a.L antibody, adora2a antibody, adora2ab antibody
- 背景
-
Background: Receptor for adenosine. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase.
Aliases: A2AAR antibody, A2aR antibody, AA2AR_HUMAN antibody, ADENO antibody, Adenosine A2 receptor antibody, Adenosine A2a receptor antibody, Adenosine receptor A2a antibody, Adenosine receptor subtype A2a antibody, ADORA 2 antibody, ADORA2 antibody, ADORA2A antibody, hA2aR antibody, RDC 8 antibody, RDC8 antibody
- UniProt
- P29274
- 途径
- Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
-